Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data”

Detalles Bibliográficos
Autores principales: Müntze, Jonas, Nordbeck, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851997/
https://www.ncbi.nlm.nih.gov/pubmed/31298731
http://dx.doi.org/10.1002/cpt.1533
_version_ 1783469736379547648
author Müntze, Jonas
Nordbeck, Peter
author_facet Müntze, Jonas
Nordbeck, Peter
author_sort Müntze, Jonas
collection PubMed
description
format Online
Article
Text
id pubmed-6851997
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68519972019-12-12 Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data” Müntze, Jonas Nordbeck, Peter Clin Pharmacol Ther Perspectives John Wiley and Sons Inc. 2019-07-12 2019-11 /pmc/articles/PMC6851997/ /pubmed/31298731 http://dx.doi.org/10.1002/cpt.1533 Text en © 2019 The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Perspectives
Müntze, Jonas
Nordbeck, Peter
Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data”
title Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data”
title_full Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data”
title_fullStr Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data”
title_full_unstemmed Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data”
title_short Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real‐World Data”
title_sort response to “oral chaperone therapy migalastat for the treatment of fabry disease: potentials and pitfalls of real‐world data”
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851997/
https://www.ncbi.nlm.nih.gov/pubmed/31298731
http://dx.doi.org/10.1002/cpt.1533
work_keys_str_mv AT muntzejonas responsetooralchaperonetherapymigalastatforthetreatmentoffabrydiseasepotentialsandpitfallsofrealworlddata
AT nordbeckpeter responsetooralchaperonetherapymigalastatforthetreatmentoffabrydiseasepotentialsandpitfallsofrealworlddata

Ejemplares similares